Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 68084-480

13 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68084-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp48001

Ahp48001
Oxybutynin Chloride Extended Release 10 mg oral tablet, white and round with imprint 'K11' on one side and '270' on the opposite side. This extended-release tablet is manufactured by American Health Packaging.*
FDA Label Image

Ahp61021

Ahp61021
Oxybutynin Chloride Extended Release 10 mg tablet, oral dosage form. The round white tablet is imprinted with 'KU' on one side and '271' on the other. Manufactured by American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure diagram of Oxybutynin Chloride, showing its molecular composition with labeled groups and hydrochloride salt.*
FDA Label Image

Figure 1: Mean R-oxybutynin Plasma Concentrations Following A Single Dose Of Oxybutynin Chloride Extended-release Tablets 10 mg And Oxybutynin 5 mg Administered Every 8 Hours (n=23 For Each Treatment) (Figure 1)

Figure 1: Mean R-oxybutynin Plasma Concentrations Following A Single Dose Of Oxybutynin Chloride Extended-release Tablets 10 mg And Oxybutynin 5 mg Administered Every 8 Hours (n=23 For Each Treatment) (Figure 1)
A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours following administration of oxybutynin chloride extended-release tablets 10 mg once daily (QD) versus oxybutynin 5 mg three times daily (TID). The graph includes error bars showing variability at each time point.*
FDA Label Image

Figure 2: Mean Steady State (± Sd) R-oxybutynin Plasma Concentrations Following Administration Of 5 To 20 mg Oxybutynin Chloride Extended-release Tablets Once Daily In Children Aged 5–15. Plot Repr (Figure 2)

Figure 2: Mean Steady State (± Sd) R-oxybutynin Plasma Concentrations Following Administration Of 5 To 20 mg Oxybutynin Chloride Extended-release Tablets Once Daily In Children Aged 5–15. Plot Repr (Figure 2)
A pharmacokinetic curve showing mean extended-release oxybutynin plasma concentrations (ng/mL) plotted over time in hours, from 0 to 24 hours. The graph includes error bars representing variability in concentration measurements at each time point.*
FDA Label Image

Figure 3: Mean Change (±sd) In Urge Incontinence Episodes Per Week From Baseline (study 1) (Figure 3)

Figure 3: Mean Change (±sd) In Urge Incontinence Episodes Per Week From Baseline (study 1) (Figure 3)
A horizontal error bar chart showing mean change (±SD) in episodes per week from baseline for oxybutynin chloride extended-release tablets and placebo. The chart compares the effect of the extended-release tablets versus placebo on episodes per week, with data points and error bars displayed along a horizontal axis ranging from -40 to 40.*
FDA Label Image

Figure 4: Mean Change (±sd) In Urge Urinary Incontinence Episodes Per Week From Baseline (study 2) (Figure 4)

Figure 4: Mean Change (±sd) In Urge Urinary Incontinence Episodes Per Week From Baseline (study 2) (Figure 4)
A horizontal bar graph depicting the mean change in episodes per week from baseline for oxybutynin chloride extended-release tablets. The central marker indicates the mean change, with error bars showing the standard deviation range extending to both negative and positive values.*
FDA Label Image

Figure 5: Mean Change (±sd) In Urge Urinary Incontinence Episodes Per Week From Baseline (study 3) (Figure 5)

Figure 5: Mean Change (±sd) In Urge Urinary Incontinence Episodes Per Week From Baseline (study 3) (Figure 5)
A horizontal bar chart showing mean change with standard deviation in episodes per week from baseline. Two separate bars represent oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40 with markers at -20, 0, 20, and 40.*
FDA Label Image

5mg Oxybutynin_chloride Er Tablets Usp 50ud Carton (5mg Oxybutynin Chloride Er Tablets Usp 50ud Carton)

5mg Oxybutynin_chloride Er Tablets Usp 50ud Carton (5mg Oxybutynin Chloride Er Tablets Usp 50ud Carton)
Label for Oxybutynin Chloride Extended Release Tablets USP 5 mg, oral tablet form, containing 50 tablets (5 x 10 count). The label shows both the front and part of the back with dosage strength, NDC 68084-480-65, and labeler American Health Packaging. It includes storage instructions, usage warning, and a QR code for prescribing information.*
FDA Label Image

5mg Oxybutynin_chloride Er Tablets Usp 100ud Carton (5mg Oxybutynin Chloride Er Tablets Usp 100ud Carton)

5mg Oxybutynin_chloride Er Tablets Usp 100ud Carton (5mg Oxybutynin Chloride Er Tablets Usp 100ud Carton)
Oxybutynin Chloride Extended-Release Tablets USP 5 mg oral tablets, packaged as 100 tablets (10 x 10) by American Health Packaging. The label includes dosage and storage instructions, barcode, NDC 68084-480-01, and QR code for prescribing information. The label emphasizes extended-release formulation and prescription use only.*
FDA Label Image

5 mg Oxybutynin Chloride Extended-release Tablets Blister (5 mg Blister 01)

5 mg Oxybutynin Chloride Extended-release Tablets Blister (5 mg Blister 01)
Oxybutynin Chloride Extended Release 5 mg tablet blister packaging label from American Health Packaging. The label includes the product name, strength, LOT number 123456, and expiration date 01/18. The tablets are arranged in a strip with multiple identical labels on the sheet.*
FDA Label Image

10mg Oxybutynin_chloride Er Tablets Usp 30ud Carton (10mg Oxybutynin Chloride Er Tablets Usp 30ud Carton)

10mg Oxybutynin_chloride Er Tablets Usp 30ud Carton (10mg Oxybutynin Chloride Er Tablets Usp 30ud Carton)
Oxybutynin Chloride Extended Release Tablets USP, 10 mg strength, oral extended-release tablets packaged as 30 tablets (3 x 10) labeled by American Health Packaging. The label includes the NDC 68084-610-21, dosage details, barcode, storage instructions, and a QR code for current prescribing information. It is an Rx only medication.*
FDA Label Image

10 mg Oxybutynin Chloride Extended-release Tablets Blister (10 mg Blister 01)

10 mg Oxybutynin Chloride Extended-release Tablets Blister (10 mg Blister 01)
Sheet of labels for Oxybutynin Chloride Extended Release Tablets USP 10 mg from American Health Packaging. Each label includes the product name, strength, dosage form, barcodes, and spaces for lot number and expiration date. The labels are arranged in pairs on the sheet, suitable for packaging use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.